Kyeongmee Park Selected Research

Kyeongmee Park Research Topics

Disease

17	Neoplasms (Cancer) 06/2017 - 06/2002
16	Breast Neoplasms (Breast Cancer) 06/2017 - 06/2002
6	Adenocarcinoma 09/2017 - 05/2005
6	Carcinoma (Carcinomatosis) 01/2016 - 11/2003
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012 - 11/2003
2	Carcinogenesis 09/2017 - 03/2009
2	Neoplasm Metastasis (Metastasis) 03/2009 - 01/2003
2	Uterine Cervical Dysplasia 07/2007 - 05/2005
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2007 - 05/2005
2	Colorectal Neoplasms (Colorectal Cancer) 01/2006 - 03/2004
1	Epstein-Barr Virus Infections 09/2017
1	Lymphatic Metastasis 07/2017
1	Triple Negative Breast Neoplasms 09/2016
1	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2016
1	Margins of Excision 06/2016
1	Pleural Effusion (Pleural Effusions) 04/2013
1	Metaplasia 02/2013
1	Gastritis 02/2013
1	Histiocytic Necrotizing Lymphadenitis (Kikuchi Disease) 09/2012
1	Adenolymphoma 09/2011
1	Prostatic Neoplasms (Prostate Cancer) 06/2008
1	Tonsillitis 04/2007
1	Adenocarcinoma of Lung 01/2006
1	Adenoid Cystic Carcinoma (Cylindroma) 05/2005
1	Rupture 04/2003

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 09/2017 - 06/2002
4	ErbB Receptors (EGF Receptor)IBA 02/2013 - 11/2003
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2011 - 06/2002
3	Hormones (Hormone)IBA 07/2017 - 06/2008
3	Progesterone Receptors (Progesterone Receptor)IBA 07/2017 - 06/2016
3	SilverIBA 06/2017 - 12/2011
3	Estrogen ReceptorsIBA 09/2016 - 01/2003
3	Fluorouracil (Carac)FDA LinkGeneric 09/2011 - 08/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2006 - 06/2002
2	human ERBB2 proteinIBA 07/2017 - 06/2016
2	Trastuzumab (Herceptin)FDA Link 05/2013 - 06/2002
2	MucinsIBA 04/2013 - 04/2003
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2013 - 07/2011
2	Vascular Endothelial Growth Factor DIBA 02/2013 - 07/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2013 - 07/2011
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 02/2013 - 07/2011
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2013 - 07/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2013 - 07/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013 - 07/2011
2	Methotrexate (Mexate)FDA LinkGeneric 09/2011 - 08/2003
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2005 - 03/2004
2	Cyclin D1IBA 08/2003 - 01/2003
1	Interleukin-17 (Interleukin 17)IBA 09/2017
1	CytokinesIBA 09/2017
1	Interleukin-6 (Interleukin 6)IBA 09/2017
1	Epidermal Growth Factor (EGF)IBA 09/2016
1	Phenobarbital (Luminal)FDA Link 09/2016
1	Estrogens (Estrogen)FDA Link 09/2016
1	Keratin-20 (Cytokeratin 20)IBA 01/2016
1	Formaldehyde (Formol)FDA Link 05/2013
1	ParaffinIBA 05/2013
1	Growth Factor ReceptorsIBA 02/2013
1	Keratins (Keratin)IBA 10/2012
1	DesminIBA 10/2012
1	S100 Proteins (S 100 Protein)IBA 10/2012
1	VimentinIBA 10/2012
1	MyogeninIBA 10/2012
1	Granzymes (Granzyme)IBA 09/2012
1	AntibodiesIBA 04/2012
1	Carcinoembryonic AntigenIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 09/2011
1	Vinorelbine (Navelbine)FDA LinkGeneric 09/2011
1	Insulin (Novolin)FDA Link 07/2011
1	taxaneIBA 07/2010
1	Docetaxel (Taxotere)FDA Link 06/2009
1	Epirubicin (Ellence)FDA LinkGeneric 06/2009
1	OsteopontinIBA 03/2009
1	Messenger RNA (mRNA)IBA 03/2009
1	NF-kappa B (NF-kB)IBA 03/2009
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 07/2007
1	Cyclin AIBA 04/2007
1	Cyclin B1IBA 04/2007
1	SurvivinIBA 04/2007
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 08/2006
1	Melanins (Melanin)IBA 06/2006
1	Inhibins (Inhibin)IBA 05/2006
1	activin AIBA 05/2006
1	Phosphotransferases (Kinase)IBA 01/2006
1	Monoclonal AntibodiesIBA 05/2005
1	ErbB-2 ReceptorIBA 05/2005
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2004
1	Retinoblastoma ProteinIBA 11/2003
1	Cyclin EIBA 08/2003
1	Tamoxifen FDA LinkGeneric 01/2003
1	CyclinsIBA 01/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2002
1	B 31IBA 06/2002

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 05/2013 - 08/2003
3	Therapeutics 09/2016 - 01/2003
3	Radiotherapy 06/2016 - 11/2003
3	Segmental Mastectomy (Lumpectomy) 06/2016 - 01/2007
3	Adjuvant Chemotherapy 09/2011 - 08/2006
2	Neoadjuvant Therapy 07/2010 - 06/2009
1	Nephroureterectomy 01/2016
1	Brachytherapy 06/2010